Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. (Q53985908)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. |
scientific article |
Statements
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. (English)
1 reference
C Blomqvist
1 reference
A Buzdar
1 reference
W Jonat
1 reference
A Howell
1 reference
S E Jones
1 reference
C L Vogel
1 reference
W Eiermann
1 reference
J M Wolter
1 reference
M Azab
1 reference
A Webster
1 reference
P V Plourde
1 reference
1 July 1996
1 reference
14
1 reference
2000-2011
1 reference
7
1 reference
Identifiers
1 reference